Current treatments of AD primarily include cholinesterase inhibitors (tacrine [10], donepezil [11], rivastigmine [11], and galantamine [11]) and the noncompetitive N-methyl-D-aspartic acid (NMDA) receptor inhibitor memantine [12]. This evidence concerns the gene BCHE and Alzheimer disease.